<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04092842</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-SIL-2017-70</org_study_id>
    <nct_id>NCT04092842</nct_id>
  </id_info>
  <brief_title>Evaluation of a New Technique to Fill the Defect Generated After Conservative Surgery in Breast Cancer</brief_title>
  <acronym>PROSILMA</acronym>
  <official_title>Evaluation of a New Technique to Fill the Defect Generated After Conservative Surgery in Breast Cancer: Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The placement of a small silicone prosthesis in the partial defects generated by conservative
      breast cancer surgery improves the aesthetic result, compared to the usual surgical
      technique, in a safe and reproducible way and compatible with adjuvant treatments. It could
      also potentially improve the quality of life of patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Conservative surgery in breast cancer is performed more than 50% of cases, however, aesthetic
      results are suboptimal, because reconstructive techniques are performed in less than 5% of
      them. Objective: To demonstrate that the placement of a silicone prosthesis in partial
      defects generated by breast cancer conservative surgery improves the aesthetic result,
      compared to the usual surgical technique, safely, reproducibly and compatible with adjuvant
      treatments.

      Methodology: Prospective randomized clinical trial, controlled with blind evaluator.
      Inclusion criteria: Women with breast cancer candidates for conservative surgery.
      Intervention: In the cases the study technique will be carried out consisting in the filling
      of the defect with a silicone prosthesis of size adjusted to it (2-4cm). Controls: usual
      surgical procedure. Main result variable: aesthetic results (visual analog scale) according
      to the patient, surgeon and blind external evaluator. Secondary variables: surgical
      complications, local complications derived from adjuvant treatments, rate of local
      recurrence, rate of reintervention due to affected margins, behavior in mammographic
      follow-up, professional satisfaction and impact on quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 18, 2019</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group whith silicone prothesis Group whith standard surgical procedure</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aesthetic result</measure>
    <time_frame>4 weeks</time_frame>
    <description>Aesthetic result of the new technique by applying a visual analog scale for measuring patient satisfaction.
Scale ranges: minimum score: 0 (no satisfaction - worse outcome), maximum score: 10 (total satisfaction - better outcome)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>4 weeks</time_frame>
    <description>Incidence of surgical complications.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Breast Conserving Surgery</condition>
  <arm_group>
    <arm_group_label>Group intervention: Silicone prothesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Breast cancer conservative surgery will be performed by removing the tumor according to the usual technique and then the defect generated will be filled with a silicone prosthesis of the same size. Said prosthesis will be covered with fat and subcutaneous cellular tissue and then the skin will be closed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group control: Usual surgical technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Breast cancer conservative surgery will be performed according to the usual surgical technique, that is, removing the tumor and covering the defect by mobilizing the breast tissue and then closing the skin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Silicone prosthesis</intervention_name>
    <description>Silicone prosthesis</description>
    <arm_group_label>Group intervention: Silicone prothesis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Usual practice</intervention_name>
    <description>Usual surgery</description>
    <arm_group_label>Group control: Usual surgical technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Women, over 18 years old, with breast cancer who attend breast pathology consultations at
        the Sant Pau Hospital in which conservative surgery is indicated.

        Exclusion Criteria:

          -  Multicentric tumors

          -  Tumors larger than 5cm

          -  Locally advanced tumors (T4): Deep plane involvement or skin involvement

          -  Patients in stages IV (distance dissemination)

          -  Patients who need mastectomy

          -  Patients with disabilities or who do not understand the terms of the study or do not
             agree to participate in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Barbara Garcia-Valdecasas, MD</last_name>
    <phone>935537041</phone>
    <email>bgvaldecasas@santpau.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Garcia-Valdecasas, MD</last_name>
    </contact>
    <investigator>
      <last_name>Barbara Garcia-Valdecasas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 13, 2019</study_first_submitted>
  <study_first_submitted_qc>September 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2019</study_first_posted>
  <last_update_submitted>September 19, 2019</last_update_submitted>
  <last_update_submitted_qc>September 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast Neoplasms</keyword>
  <keyword>Breast Conserving Surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

